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Original ArticleFemale sex hormones are necessary for the
metabolic effects mediated by loss of Interleukin
18 signalingBirgitte Lindegaard 1,2,**,4, Julie Abildgaard 1,4, Sarah E. Heywood 1,3, Bente K. Pedersen 1,
Mark A. Febbraio 3,*ABSTRACT
Objective: Interleukin (IL)-18 plays a crucial role in maintaining metabolic homeostasis and levels of this cytokine are inﬂuenced by gender, age,
and sex hormones. The role of gender on IL-18 signaling, however, is unclear. We hypothesized that the presence of female sex hormone could
preserve the metabolic phenotype of the IL-18R/ animals.
Methods: We studied female mice with a global deletion of the a isoform of the IL-18 receptor (IL-18R/) and littermates control. Three studies
were done: 1) animals fed a high fat diet (HFD) for 16 weeks; 2) animals fed chow diet for 72 weeks and 3) animals (3 weeks-old) randomized to
either bilateral ovariectomy (OVX) or control surgery (SHAM) and followed for 16 weeks.
Results: Female IL-18R/ mice gained less weight and maintained glucose homeostasis on a chow diet compared with HFD, but no dif-
ferences between genotypes were observed. The maintenance of body weight and glucose homeostasis in IL-18R/ mice was lost with aging.
By 72 weeks of age, IL-18R/ mice became heavier compared with WT mice due to an increase in both visceral and subcutaneous adiposity
and displayed glucose intolerance. OVX did not affect body weight in IL-18R/ mice but exacerbated glucose intolerance and impaired liver
insulin signaling when compared with SHAM mice.
Conclusions: Female mice harboring a global deletion of the IL-18R, only present the same phenotype as reported in male IL-18R/ mice if
they are aged or have undergone OVX, in which circulating estrogen is likely to be blunted. The role of estrogen signaling in the protection against
altered metabolic homeostasis in IL-18R/ mice appears to be mediated by liver insulin signaling. We therefore suggest that the metabolic
effects mediated by loss of IL-18 signaling are only present in a female sex hormone free environment.
 2018 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Interleukin (IL)-18 is a cytokine belonging to the cytokine family of IL-1.
It is known to signal through stimulation of IFN-g [1] and is activated by
pro-inﬂammatory stimuli such as LPS, Fas ligand, and TNF-a leading
to caspase-1-mediated cleavage of pro-IL-18 into mature IL-18. IL-18
signals via a heterodimer of the transmembrane IL-18 receptors (a and
b) and ultimately activates NFkB and subsequently regulates gene
transcription. Besides this pathway, IL-18 is also involved in mitogen-
activated protein kinase PIPs kinase and Stat 3 signaling.
Over the past decade, it has become apparent that IL-18 plays a
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us [4,5] and others [6,7] that employed both loss and gain of
function in rodent models, demonstrated that IL-18 was both
necessary and sufﬁcient for the maintenance of metabolic homeo-
stasis. In our recent study where we showed that mice that harbor a
global deletion of the functional IL-18R are prone to gain weight,
increased ectopic skeletal muscle lipid expression, inﬂammation
and, ultimately insulin resistance, all experiments were performed in
male mice [4]. It is important to note that IL-18 levels are inﬂuenced
by gender [8], age [9], and sex hormones [10]. Moreover, lack of
female sex hormones is associated with increased adiposity and
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Original Articlerole of IL-18 signaling on metabolic homeostasis in female mice
and, importantly, the role that the sex hormones may play in this
experimental model is unclear. We, therefore, hypothesized that the
presence of female sex hormone could preserve the metabolic
phenotype of the IL-18R/ animals. We tested the hypothesis in a
diet-induced obesity model in both aged female mice and ovariec-
tomized IL-18R/ animals. We show that the lack of IL-18
signaling and female sex hormones combined, but not IL-18 or
female sex hormone per se, leads to systemic insulin resistance and
impaired insulin signaling in the liver.
2. MATERIALS AND METHODS
2.1. Animal experimental protocol
All experiments were approved by The Animal Experiments Inspec-
torate in Denmark. For the aging study, twelve-week-old IL18R/
(mice deﬁcient in IL-18 receptor 1, backcrossed 11 generations to
C57BL/6J) and wild-type C57BL/6J mice were obtained from Charles
River Laboratories (L’Arbresle, France). For the ovariohysterectomy
(OVX) and diet-induced obesity (DIO) study, IL18R/ and littermate
control (WT) mice were obtained from heterozygous breeding. Mice
were maintained on a 12-h light, 12-h dark cycle on a standard rodent
chow diet (27%, 13%, and 60% kcal from protein, fat, and carbo-
hydrate, respectively) for the aging and OVX study. For the DIO study,
a high fat diet composed of 60% calories from fat (Research Diet
12492) was administered when the mice were 16 weeks old of age
and continued for 16 weeks (DIO study). For the OVX study, 3 weeks
old female, IL18R/, and WT mice were randomly divided into 2
groups, sham (SHAM) operated and OVX operated, and anesthetized
with a Hypnorm (10 mg/ml) (vetPharma Ltd, Leeds, UK) and Mid-
azolam (5 mg/ml) (Hameln pharmaceuticals, Hameln, Germany)
(1:1:2) anesthetic mixture with sterile water as the last component,
administered subcutaneously (s.c) (0.1 ml per 10 g body weight) and
were OVX or SHAM operated. In the OVX animals, the ovary was
isolated and allocated to the incised muscles; the oviduct was ligated
with 6-0 absorbable Vicryl ligature (Ethicon, Norderstedt, Germany),
and the ovary removed. This procedure was performed on both
ovaries and the muscle incisions and the skin incision were closed
with 5-0 absorbable Vicryl (Ethicon) with interrupted sutures. The
SHAM operated females were incised as described above, through the
skin and abdominal muscles, and the incisions were closed as
described above.
2.2. Body composition measurements
Body weights were monitored weekly throughout the DIO and OVX
study. At the cessation of the studies, we analyzed body composition
by quantitative MRI using EchoMRI (Echo Medical Systems, Houston,
TX, USA). Fat and lean mass percentages were calculated in relation to
total body weight, which was measured prior to the MRI scan. To
conﬁrm the MRI ﬁndings, mice were killed and the gonadal, retro-
peritoneal, and inguinal fat pads were dissected and weighed.
2.3. Insulin tolerance tests
In the DIO-study, we performed an insulin tolerance test after 16
weeks of HFD, in the aging study in 16 months-old female mice, and
in the OVX study 16 weeks after OVX/SHAM operations, 4 h after
removal of food. Blood samples were obtained by tail cut and analyzed
for glucose using a glucometer (Accu-chek Compact plus) immedi-
ately before and at 15, 30, 45, 60, 90, and 120 min after an intra-
peritoneal injection of insulin (0.75 U/kg lean body weight Actrapid,
Novo Nordisk, DK).90 MOLECULAR METABOLISM 12 (2018) 89e97  2018 The Authors. Published by Elsevier GmbH. T
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In the DIO study and the OVX study, we performed intraperitoneal
glucose tolerance tests after 16 weeks of HFD feeding and 16 weeks
after OVX, respectively, and after removal of food for 14 h. Blood
samples were obtained by tail cut and analyzed for glucose using a
glucometer (Accu-chek Compact plus) immediately before and at 15,
30, 45, 60, 90, and 120 min after an intraperitoneal injection of
glucose (2 g/kg body weight). In the OVX and aging study, we per-
formed an oral glucose tolerance test 16 weeks after OVX and in 9
months- (36 weeks) and in 18 (72 weeks) months-old female mice,
respectively, after removal of food for 14 h. Blood samples were ob-
tained by tail cut and analyzed for glucose content using a glucometer
(Accu-chek Compact plus) immediately before and at 15, 30, 45, 60,
90, and 120 min after an oral gavage of glucose (2 g/kg body weight).
2.5. Measurement of blood samples
Blood samples were obtained from the tail vein, transferred into EDTA
tubes, spun at 6000 g for 10 min at 4 C, and the plasma was removed.
Plasma was stored at 80 C until analysis. Plasma insulin was
determined by ELISA (Crystal Chem). Blood glucose was measured by
glucometer (Accu-chek Compact Plus).
2.6. Insulin signaling tissue collection
In the OVX study, insulin signaling in liver, adipose tissue, and skeletal
muscle was studied. Animals were given an intraperitoneal injection of
insulin (1.5 units/kg lean body mass). After 5 min, the animals were
sacriﬁced by cervical dislocation and the tissue removed.
2.7. Protein analyses
Tissues of interest were homogenized in an ice-cold lysis buffer
(50 mM Tris, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 50 mM NaF,
5 mM NaP, 2 mM NaV, 1 mM DTT, 0.2% Ipegal-CA-630, protease
inhibitor (Roche Applied Science), 1% phosphatase inhibitor cocktail,
pH 7.4) for 2 min using a tissue lysate with 30 oscillations/s (Tis-
sueLyser II; QIAGEN, Germany). Lysates were generated by centrifu-
gation (16,000 g) for 15 min at 4 C. Protein concentration in lysates
was measured by the Bradford reagent (BioRad) [15].
Tissue lysates were subjected to SDS-PAGE using BioRad 4e15% pre-
cast gels and I-blot semi-dry transfer machine according to the manu-
facturer’s instructions. Samples from all groups were loaded in even
numbers on the same gel. PVDF membranes were probed with primary
antibodies raised against the protein of interest; p-AMPK(Thr172) (#2535,
Cell Signaling Technology, Danvers, MA), p-Akt(Ser473) (#9271, Cell
Signaling Technology, Danvers, MA), p-GSK3 a/b (Ser21/9) (#9331 Cell
Signaling Technology, Danvers, MA, USA), p-ACC(Ser79) (#3661, Cell
Signaling Technology, Danvers, MA), p-JNK(Thr183/Tyr185) (#9251, Cell
Signaling Technology, Danvers, MA), p-STAT3(Tyr705) (#9131, Cell
Signaling Technology, Danvers, MA), total AKT (#9272, Cell Signaling
Technology, Danvers, MA). Detection of primary antibodies was per-
formed using appropriate peroxidase-conjugated IgG and protein signals
visualized using FEMTO enhanced chemiluminescence and Biorad
Chemidoc XRS imager. Total protein content was quantiﬁed using reactive
brown 10 (SigmaeAldrich, St-Louis, MO). Quantiﬁcation of immunoblots
was done using ImageJ (NIH, Bethesda, MD, http://rsb.info.nih.gov/ij).
2.8. Statistical analyses
All analyses were performed using SAS 9.2. Analyses with two vari-
ables were tested with a two way ANOVA followed by a Tukeys post
hoc test. Time-series data were analyzed with PROC MIXED. Effects of
insulin stimulation on genotype and OVX were analyzed using a three-
way ANOVA. p < 0.05 was considered signiﬁcant.his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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3. RESULTS
3.1. Female IL-18 receptor-deﬁcient mice gain less weight and
maintain glucose homeostasis
As discussed above, IL-18 levels are inﬂuenced by gender. Accord-
ingly, we ﬁrst measured the mRNA of the gene encoding IL-18R in
skeletal muscle, white adipose tissue (WAT) and liver of male andFigure 1: Whole-body phenotype and glucose metabolism of chow-, and HFD-fed fe
CON-HFD: n ¼ 12; IL-18R/-chow: n ¼ 10; IL-18R/-HFD: n ¼ 12). B: Total mass (TM
18R/-chow: n ¼ 10). C: Total mass (TM), lean body mass (LBM), and fat mass (FM)
tolerance during chow and HFD, 16 weeks after start of the study with area under the curv
HFD: n ¼ 12; IL-18R/-HFD: n ¼ 12). E: Intraperitoneal insulin tolerance test in females d
inserted for chow and HFD (CON-chow: n ¼ 11; IL-18R/-chow: n ¼ 10; CON-HFD: n ¼
0.5 mU/kg was used for chow and HFD, respectively. Results are presented as mean 
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skeletal muscle and WAT, the IL-18R mRNA expression was higher in
the liver of females compared with males (Supplementary Figure 1). To
evaluate the role of IL-18 signaling and body weight homeostasis in
female mice, we performed loss-of-function studies in female mice
with a global deletion of alpha-isoform of the IL-18 receptor and IL-18
(IL-18R/). In contrast with our previous observations in malemale IL-18R/ mice. A: Growth curves during chow and HFD (CON-chow: n ¼ 12;
), lean body mass (LBM), and fat mass (FM) during chow diet (CON-chow: n ¼ 12; IL-
during HFD (CON-HFD: n ¼ 12; IL-18R/-HFD: n ¼ 12). D: Intraperitoneal glucose
e (AUC) inserted for chow and HFD (CON-chow: n ¼ 12; IL-18R/-chow: n ¼ 9; CON-
uring chow and HFD, 16 weeks after start of the study, with area under the curve (AUC)
11; IL-18R/-HFD: n ¼ 12). In the intraperitoneal insulin tolerance test 0.3 mU/kg and
SEM. ***p < 0.0001 vs chow (A,D); *p < 0.05 (B); xp ¼ 0.054 vs CON chow.
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Original ArticleIL-18R/ [4], female IL-18R/ mice did not become heavier
compared with WT, irrespective of diet. In fact, there was a tendency
for body weight to be lower in IL-18R/ mice compared with WT
mice (Figure 1A). In contrast with male IL-18R/ mice [4], female
IL-18R/ mice had a reduced total lean body mass compared with
CON on a chow (Figure 1B) but not HFD (Figure 1C). We next examined
whether eight-month-old chow and HFD fed female IL-18R/ mice
exhibited whole body metabolic disturbances. No difference in glucose
tolerance was observed between genotype irrespective of diet
(Figure 1D), however, IL-18R/ mice fed a chow diet tended to
become more insulin sensitive (p ¼ 0.056) compared with WT mice,
but no differences were observed between genotypes when mice were
fed a HFD (Figure 1E).
3.2. The maintenance of body weight and glucose homeostasis in
female IL-18 receptor deﬁcient mice is lost with aging
As no differences in obesity or glucose tolerance were observed
between female CON and IL-18R/ animals, we hypothesized that
this effect was mediated by female sex hormones. Although mice do
not undergo a true menopause, female mice exhibit ovarian failure,
which is signiﬁcant around 14 month of age [16] and develops many
of the same age-associated health complications, including bone and
muscle loss and excess fat deposition, as is observed in post-
menopausal women [17]. Therefore, we initially studied the effect of
aging on the phenotype and followed chow fed, female CON and
IL-18R/ mice from 32 to 72 weeks of age. While normal bodyFigure 2: Whole-body phenotype and glucose metabolism of aging female IL-18R/
n¼ 42). B: Gonadal, retroperitoneal, and inguinal fat pads in 72 weeks old fasted animals (CO
inserted in 72 weeks old animals (CON: n ¼ 8; IL-18R/ n ¼ 10). Results are presented a
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IL-18R/ mice became heavier compared with CON (Figure 2A). The
increase in body weight was due to an increase in both visceral and
subcutaneous adiposity when fat pads were obtained and weighed at
72 weeks of age (Figure 2B). We next evaluated glucose homeostasis
over the same time-course. Consistent with body mass data, no
difference was observed between genotypes at 36 weeks of age
(Figure 2C; left panel), but by the age of 72 weeks, when IL-18R/
had increased fat mass, we also observed glucose intolerance in
these mice (Figure 2C; right panels). Somewhat paradoxically, at this
age, the IL-8R/ animals had a lower liver weight (Supplementary
Figure 2A).
3.3. Ovariectomy exacerbates glucose intolerance and impaired
liver insulin signaling but not body weight, in IL-18R/ mice
As the phenotype in aging mice may have been explained by the
progressive loss of circulating female sex hormones, we next per-
formed an OVX study in which chow fed IL-18R/ female and WT
animals underwent surgery at 7 weeks and were followed subse-
quently for 16 weeks. Irrespective of genotype, OVX mice gained more
weight compared with SHAM, but no differences were observed be-
tween genotypes (Figure 3A). The increase in body mass was due to a
marked increase in adiposity, since OVX resulted in a loss of lean mass
(Figure 3B). The increased adiposity was attributable to increases in
both visceral and subcutaneous fat mass, with no difference between
genotype (Figure 3C).mice. A: Body weight for 32, 36, 55, and 72 weeks old animals (CON-: n¼ 28 IL-18R/
N-: n¼ 10; IL-18R/ n¼ 13); C: Oral glucose tolerance with area under the curve (AUC)
s mean  SEM. *p < 0.05 (A, B, C) and **p < 0.01 vs CON (B).
his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 3: Whole-body phenotype of ovariectomized female IL-18R/ mice. A: Growth curve for sham and Ovariectomized (OVX) mice (CON-Sham: n ¼ 10; CON-Ovx
n ¼ 10; IL-18R/-Sham: n ¼ 10; IL-18R/-Ovx: n ¼ 10). B: Fat and lean mass for Sham and Ovariectomized (OVX) mice; C: Gonadal, retroperitoneal, and inguinal fat
pads in Sham and Ovariectomized (OVX) mice. Results are presented as mean  SEM. ***p < 0.001 vs Sham (A, B, C).Despite the fact that OVX did not affect body weight when comparing
IL-18R/ with WT mice, we also examined metabolic homeostasis as
we have previously observed uncoupling between body weight and
glucose homeostasis with gene deletion in mice [18]. Consistent with
such uncoupling of metabolism to body mass, OVX caused glucose
intolerance in IL-18R/ compared with WT mice, as measured
by IPGTT (Figure 4A) and during an oral glucose tolerance test
(OGTT) (Figure 4B). The impairment in glucose tolerance observed in
IL-18R/ was likely to be due to insulin resistance rather than a
defect in insulin secretion since no differences were observed in insulin
concentration when comparing genotypes during the OGTT (Figure 4C).
To investigate insulin resistance in adipose tissue, we measured
circulating non-esteriﬁed fatty acid (NEFA) concentrations during the
OGTT as a proxy marker. IL-18R/ SHAM animals display increased
circulating NEFA concentrations after fasting compared with WT
SHAM-operated animals (Figure 4D). However, consistent with
a normal glucose tolerance during an OGTT in SHAM-operated
IL-18R/ animals, SHAM-operated IL-18R/ animals exhibited
similar NEFA concentrations and percentage drop in NEFA concen-
trations during an OGTT compared with SHAM-operated WT animals,
indicative of normal suppression of lipolysis during an OGTT and,MOLECULAR METABOLISM 12 (2018) 89e97  2018 The Authors. Published by Elsevier GmbH. This is an open ac
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and consistent with impaired glucose tolerance in IL-18R/ OVX
mice, we observed an impaired suppression of NEFA during the OGTT
in these animals compared with other groups, indicating insulin
resistance in the adipose tissue (data not shown). Somewhat sur-
prisingly, OVX animals had lower liver triacylglycerol levels irrespective
of genotype (Supplementary Figure 2B). Taken together and coupled
with the data in aged animals, these data indicate that the IL-18
signaling mediated defect in glucose metabolism is dependent upon
the loss of female sex hormones.
In order to gain insight into a possible mechanism for the aforemen-
tioned observations, we next interrogated insulin signaling in liver,
skeletal muscle, and adipose tissue by measuring phosphorylation of
Akt at the Serine 473 site, 2 min after a bolus of insulin in SHAM and
OVX IL-18R/ and WT animals. In liver, OVX IL-18R/ animals had
impaired Akt phosphorylation relative to other groups (Figure 5A). In
contrast, no such effect was observed in adipose tissue. (Figure 5B).
We also measured the phosphorylation of the downstream target of
Akt, namely GSK3. Consistent with the data for Akt phosphorylation,
we saw little effect of either IL18R/ or OVX on this measure
(Supplementary Figure 3). We previously demonstrated that IL-18cess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 93
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Figure 4: Ovariectomized IL-18R/ mice exhibit impaired glucose tolerance and insulin resistance. A: Intraperitoneal glucose tolerance with area under the curve (AUC)
inserted in Sham and ovariectomized mice 16 weeks after operation (CON-Sham: n ¼ 10; CON-OVX n ¼ 9; IL-18R/-Sham: n ¼ 9; IL-18R/-Ovx: n ¼ 10). B: Oral glucose
tolerance with area under the curve (AUC) inserted in Sham and Ovx animals 17 weeks after operation (CON-Sham: n ¼ 10; CON-OVX n ¼ 10; IL-18R/-Sham: n ¼ 9; IL-
18R/-OVX: n ¼ 10); C: Plasma insulin during an oral glucose tolerance test in Sham and Ovx animals 17 weeks after operation (CON-Sham: n ¼ 10; CON-OVXx n ¼ 10; IL-
18R/-Sham: n ¼ 9; IL-18R/-OVX: n ¼ 10); D: Fasted NEFA concentration in Sham and Ovx animals 17 weeks after operation (CON-Sham: n ¼ 10; CON-OVX n ¼ 10; IL-
18R/-Sham: n ¼ 9; IL-18R/-OVX: n ¼ 10). Results are presented as mean  SEM. *p < 0.05 vs CON Sham (A, B, D: one-way ANOVA, difference between four groups);
*p < 0.05 vs CON Sham/KO Sham and CON OVX (A, B: No difference between CON Sham and KO sham and the groups were pooled to one group. One-way ANOVA between three
groups); ##p < 0.01 (C: CON OVX and KO OVX vs CON Sham); xp ¼ 0.056 versus CON OVX, CON Sham and KO sham, two-way ANOVA (4 groups (CON-sham, CON-OVX,
KO-sham, KO-OVX) and Time (15 and 30 min)).
Original Article
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Figure 5: Ovariectomized IL-18R/ mice exhibit impaired insulin signaling in liver. Total and phosphorylated Ser473 Akt during Sham and OVX in liver (A), muscle (B), and
adipose tissue (C) before and after insulin stimulation. No Insulin (); Insulin stimulation (þ). Samples from Sham and OVX were run on the same gel and related to total Akt.
(n ¼ 4e6 per group). Results are presented as mean  SEM. *p < 0.05 vs CON Sham, KO Sham, CON OVX (two-way ANOVA: Class: 4 groups (CONsham CON-OVX KOsham KO-
OVX) and Insulin  4 groups). (*) ¼ p ¼ 0.056 vs CONsham.activates AMPK [4], while others [19] have demonstrated that estradiol
activates AMPK. Accordingly, we measured the phosphorylation of
AMPK in liver, skeletal muscle and white adipose tissue in this study. In
contrast with our previous work [4], we observed no effect of OVX or
genotype on AMPK phosphorylation (Supplementary Figure 4).
4. DISCUSSION
Rates of obesity, type 2 diabetes, and cardiovascular disease have
steadily risen over the past ﬁve decades. Obesity is a risk factor for
type 2 diabetes and cardiovascular disease; however, it has become
apparent that the relationship is not linear. While obesity rates are
higher in females [20], men have higher rates of related diseases [21].MOLECULAR METABOLISM 12 (2018) 89e97  2018 The Authors. Published by Elsevier GmbH. This is an open ac
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metabolic phenotypes and, for this reason, most murine studies in
diet-induced obesity have been conducted in male mice (for review see
Ref. [22]). In the current study we demonstrate that, in direct contrast
with our previous studies in male mice [4], IL-18R/ female mice do
not display obesity, insulin resistance or impaired liver insulin sensi-
tivity. However, in advanced aging, when mice lose circulating estro-
gen or after OVX, the protection observed in female IL-18 receptor
deﬁciency is lost, suggesting that the protection against metabolic
disease in these mice is driven by circulating female sex hormones.
It is well known that OVX in mice leads to obesity and insulin resistance,
and this appears to be due to loss of estrogen receptor signaling since
restoration of estrogen at physiological concentrations maintains insulincess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 95
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Original Articleaction and glucose tolerance in OVX mice [23]. Moreover, estrogen
receptor alpha-deﬁcient mice (ERa ko) are glucose intolerant and in-
sulin resistant [24,25]. However, as recently discussed, the organs/
tissues responsible for the defect are unclear. Work from the Hevener
laboratory has recently found that skeletal muscle [26] and myeloid cell
[27] speciﬁc ERa deﬁciency both lead to impaired metabolic homeo-
stasis. As IL-18 is an inﬂammatory cytokine and we recently demon-
strated that IL-18 production from the Nod-Like receptor 1 (NLRP1)
inﬂammasome prevents HFD-induced metabolic dysregulation [5], we
examined whether inﬂammation may have mediated the impaired
metabolic homeostasis observed in OVX IL-18R/ mice (Figure 4).
However, we saw no differences in several markers of inﬂammation we
measured when comparing OVX IL-18R/ with SHAM IL-18R/
mice (data not shown) indicating that the phenotype was unlikely to be
due to modiﬁcation to inﬂammatory signaling. Likewise, we measured
muscle insulin signaling and saw no effect when comparing OVX IL-
18R/ with SHAM IL-18R/ mice (data not shown), suggesting that
skeletal muscle was unlikely to be mediating the observed phenotype.
Given that we observed changes in glucose tolerance independent of
insulin secretion (Figure 4) and near complete blunting of insulin-
stimulated AKT phosphorylation in liver (Figure 5), it is likely that a
lack of estrogen receptor signaling in OVX IL-18R/ was mediated by
insulin resistance in this tissue. However, as recently discussed [28],
the role of estrogen receptor signaling on liver insulin resistance is still
unclear since some [29] but not others [25] ﬁnd a defect in hepatic
insulin action in ERa ko mice.
It must be noted that we studied IL-18R/ mice and not IL-18
deﬁcient mice in the current study. A previous study has demon-
strated some differences in the phenotypes of these two strains of
mice [30], raising the possibility that some of the actions of IL-18 may
be receptor independent. Accordingly, we performed GTT and ITT
experiments in female IL-18 KO mice and compared those data with
the data reported herein on IL-18R/ female mice. Consistent with a
previous report in male mice [6], we observed no differences when
comparing strains (data not shown), suggesting that the possibility of
IL-18 acting via mechanisms not involving it’s receptor is unlikely.
In conclusion, we have demonstrated that, unlike our previous ob-
servations in male mice harboring a whole body deletion of the IL-18R
[4], female mice harboring the same deletion do not present with this
phenotype unless they are aged or have undergone OVX where
circulating estrogen is likely to be blunted. Moreover, the role of es-
trogen signaling in the protection against altered metabolic homeo-
stasis in IL-18R/ mice appears to be mediated by liver insulin
signaling. These data have important implications for the role of IL-18
signaling in metabolism and the sexual dimorphism often observed in
murine studies with respect to insulin resistance.
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